Gencor, worldwide supplier of branded, clinically-researched botanical ingredients, announces the introduction of VeriSperse®, a unique cold-water dispersible resveratrol powder. Veri-Sperse® features Veri-te™ and LipiSperse®. Veri-te™ is a clinically-studied and award-winning technology manufactured by Evolva, a biotech developer of natural ingredients. Evolva’s resveratrol has been featured in two recently published clinical studies in The Journal of North American Menopause Society and Clinical Nutrition..
Reservatrol is a polyphenol found in plants which is recognized for its ability to work on a cellular level to support healthy aging.
It is normally limited by its preference for aqueous environments. Gencor’s VeriSperse® resveratrol overcomes this limitation by utilizing LipiSperse™ technology, developed by Pharmako, which is designed to enhance dispersion and increase bioavailability of the resveratrol up to 2 to 3 times greater. This technology provides distinct advantages over standard resveratrol, such as high active loads, improved functionality, and enhanced bioavailability. In addition, the bioavailability of VeriSperse® has been scientifically validated by a human pharmacokinetic study.
The LipiSperse™ technology acts to create a repulsion between the powder surface of VeriSperse® and solution to establish an equilibrium. The repulsion prevents particle agglomeration or aggregation, thus allowing the resveratrol to easily disperse in water. This dispersion provides for both greater absorption and overall efficacy of the Veri-te™ resveratrol.
“Given Veri-te’s™ recently published outcomes by The Journal of North American Menopause Society and Clinical Nutrition, we feel even more confident in the ability of the resveratrol to address critical life markers and symptoms for menopausal women.” Said Chase Shyroc, Vice President of Sales and Business Development for Gencor. “In marrying Veri-te™ and LipiSperse™ technologies, Veri-Sperse® Resveratrol provides a superior resveratrol that can be applied in limitless applications to support healthy aging and improved quality of life for women suffering the symptoms of menopause.”
Veri-te™ resveratrol was the focal point of RESHAW, which was a large-scale, peer-reviewed and published research project. REHSAW’s double-blind, placebo-controlled study examined the impact of the resveratrol on cognitive performance. The results from the study indicate that resveratrol may attenuate the decline in cognitive function as well as improve overall well-being in post-menopausal women. RESHAW received the “Best Nutrition Research Project” award from NutraIngredients Asia in 2020.
Veri-Sperse™ Resveratrol holds great promise as a powerful antioxidant that’s enabled by its design for increased bioavailability, efficacy and absorption. For more information on the VeriSperse™ cold water dispersible resveratrol powder, please visit
